Intra-articular Corticosteroid Injection into a Small Joint is NOT Contraindicated Before Total Hip Arthroplasty
An intra-articular corticosteroid injection into a small joint (e.g., hand, wrist, foot, ankle) is not contraindicated when a total hip arthroplasty is scheduled within three months, as the infection risk concerns apply only to injections into the ipsilateral hip joint itself.
Key Distinction: Site of Injection Matters
The critical issue here is anatomical specificity. All available evidence addresses injections into the same joint that will undergo arthroplasty—specifically, hip or knee injections before hip or knee replacement 1, 2, 3, 4.
Evidence for Hip Joint Injections (Not Applicable to Your Question)
The 2021 EULAR guidelines state that intra-articular therapy "may be performed at least 3 months prior to joint replacement surgery" for the same joint, noting infection rates increase from 0.5% to 1.0% when hip/knee injections occur within 3 months of that joint's arthroplasty 1.
The 2023 ACR/AAHKS guidelines note "increased risk of joint infection if the surgery is performed within 3 months of the intraarticular injection" but this refers specifically to injecting the joint scheduled for surgery 2.
Recent research confirms this timing-specific risk: a 2024 study found corticosteroid injection within 3 months of THA increased periprosthetic joint infection risk (HR 2.63), but only for ipsilateral hip injections 3. A 2022 meta-analysis similarly found increased infection odds (OR 1.39) only when the same joint received injection within 3 months 4.
Clinical Reasoning
Small joint injections (hands, feet, wrists, ankles) pose no theoretical or evidence-based risk to a planned hip arthroplasty because:
- Infection risk is localized to the injected joint and its immediate surgical field
- Systemic immunosuppression from a single small-joint corticosteroid injection is negligible and transient
- No evidence suggests remote joint injections affect surgical site infection rates at distant anatomical locations
- The pathophysiology of periprosthetic infection relates to local bacterial seeding, not systemic corticosteroid effects
Practical Recommendation
Proceed with small joint corticosteroid injections as clinically indicated, regardless of upcoming hip arthroplasty timing. The 3-month window restriction applies exclusively to injecting the hip joint that will undergo surgery.
Common Pitfall to Avoid
Do not extrapolate hip-to-hip injection data to unrelated anatomical sites. The evidence is joint-specific, not a blanket contraindication for all corticosteroid injections in patients awaiting arthroplasty.
Exception Worth Noting
If the patient has poorly controlled diabetes, counsel them about transient hyperglycemia risk (days 1-3 post-injection) regardless of injection site, though this is a glucose monitoring issue, not a contraindication 1.